Don’t miss the latest developments in business and finance.

Lasa Supergenerics launches new product - Oxyclozanide

Image
Capital Market
Last Updated : Jun 09 2021 | 11:50 AM IST
Lasa Supergenerics has introduced another product - Oxyclozanide to its portfolio of product.

Oxyclozanide is an anthelmintic. It is used in the treatment and control of fascioliasis a topical worm infection in ruminants mainly domestic animals such as cattle (especially buffalos in farm), sheep, and goats. For this, the Company is setting up capacity in a brown field expansion at its Chiplun unit. The total capacity would be 250 MT and The Company is committed to funding the required Capex through internal accruals. The production would start from August 2021.

The product is in huge demand and the management is confident of having a strong order book from the time production commences. The Company already has export approvals for several regions. Oxyclozanide would also be exported to these regions.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jun 09 2021 | 11:26 AM IST

Next Story